Anti-HGF/SF Antibody (Rilotumumab)
Catalog No.
F2062
Anti-HGF/SF Antibody (Rilotumumab)
Featured Products
Rilotumumab (AMG 102) is an anti-HGF (anti-hepatocyte growth factor) monoclonal antibody that inhibits HGF/MET-driven signaling. Rilotumumab has anti-tumor activity and can be used in the study of castration-resistant prostate cancer (CRPC) and solid tumors.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.2 kDa
Dry ice
872514-65-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
AMG-102, AMG 102
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P14210
Human
Unconjugated
Monoclonal
Protein A
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human HGF His at 2 ug/mL can bind Anti-HGF/SF Antibody (Rilotumumab)
HGF / SF
Please avoid freeze-thaw cycles.